Bain Capital Life Sciences Investors, LLC Q1 2022 Filing
Filed May 16, 2022
Portfolio Value
$1.0T
Holdings
34
Report Date
Q1 2022
Filing Type
13F-HR
All Holdings (34 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | SWTXSPRINGWORKS THERAPEUTICS INC | 4,831,307 | $272.7B | 26.48% | |
| 2 | DVAXDYNAVAX TECHNOLOGIES CORP | 8,415,000 | $91.2B | 8.86% | |
| 3 | ARQTARCUTIS BIOTHERAPEUTICS INC | 3,979,292 | $76.6B | 7.44% | |
| 4 | PHVSPHARVARIS N V | 3,180,601 | $57.7B | 5.60% | |
| 5 | RPIDRAPID MICRO BIOSYSTEMS INC | 8,434,560 | $57.3B | 5.56% | |
| 6 | NUVLNUVALENT INC | 3,428,014 | $47.6B | 4.62% | |
| 7 | CRNXCRINETICS PHARMACEUTICALS IN | 2,029,701 | $44.6B | 4.33% | |
| 8 | —EQRX INC | 10,003,573 | $41.3B | 4.01% | |
| 9 | CCCCC4 THERAPEUTICS INC | 1,642,210 | $39.8B | 3.87% | |
| 10 | AMLXAMYLYX PHARMACEUTICALS INC | 2,756,050 | $35.4B | 3.44% | |
| 11 | —MERSANA THERAPEUTICS INC | 6,522,030 | $26.0B | 2.53% | |
| 12 | TSVT*2SEVENTY BIO INC | 1,408,901 | $24.0B | 2.33% | |
| 13 | —APTINYX INC | 8,891,758 | $20.2B | 1.96% | |
| 14 | XLOXILIO THERAPEUTICS INC | 2,805,413 | $19.8B | 1.93% | |
| 15 | NRIXNURIX THERAPEUTICS INC | 1,284,313 | $18.0B | 1.75% | |
| 16 | AVIRATEA PHARMACEUTICALS INC | 2,485,638 | $17.9B | 1.74% | |
| 17 | YB4PSAVARA INC | 11,622,598 | $15.2B | 1.48% | |
| 18 | TNGXTANGO THERAPEUTICS INC | 1,921,790 | $14.6B | 1.41% | |
| 19 | MRNS*MARINUS PHARMACEUTICALS INC | 1,431,058 | $13.4B | 1.30% | |
| 20 | —RESEARCH ALLIANCE CORP II | 1,000,000 | $9.8B | 0.95% | |
| 21 | SLDBSOLID BIOSCIENCES INC | 7,929,918 | $9.5B | 0.92% | |
| 22 | ANNXANNEXON INC | 3,241,628 | $8.8B | 0.86% | |
| 23 | IVVDADAGIO THERAPEUTICS INC | 1,937,207 | $8.8B | 0.86% | |
| 24 | NAUTNAUTILUS BIOTECHNOLOGY INC | 2,000,000 | $8.7B | 0.84% | |
| 25 | —SYROS PHARMACEUTICALS INC | 6,264,420 | $7.5B | 0.72% | |
| 26 | —ARYA SCIENCES ACQU CORP IV | 700,000 | $6.9B | 0.67% | |
| 27 | AGLEUSDAEGLEA BIOTHERAPEUTICS INC | 2,847,689 | $6.5B | 0.64% | |
| 28 | ASNSUSDX4 PHARMACEUTICALS INC | 3,019,540 | $5.3B | 0.51% | |
| 29 | —PANACEA ACQUISITION CORP II | 500,000 | $4.9B | 0.47% | |
| 30 | —ARYA SCIENCES ACQUISITN CORP | 500,000 | $4.9B | 0.47% | |
| 31 | —BCLS ACQUISITION CORP | 487,500 | $4.8B | 0.47% | |
| 32 | —OMEGA ALPHA SPAC | 400,000 | $3.9B | 0.38% | |
| 33 | —FRAZIER LIFESCIENCES ACQU CO | 300,000 | $3.0B | 0.29% | |
| 34 | —JIYA ACQUISITION CORP | 300,000 | $2.9B | 0.29% |